MedTrace Logo

Tacrolimus in CD3+ T Lymphocytes

NCT06342505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2024-04-02

No results posted yet for this study

Summary

The goal of this study is to measure concentrations of the drug tacrolimus in both whole blood and within T lymphocytes. It will also learn on the correlation between the concentration in T lymphocytes and the effects of the drug. The main questions are:

(i) What is the ratio between the tacrolimus concentration within T lymphocytes and in whole blood?; (ii) What is the correlation between tacrolimus concentrations and the effects of the drug?

Participants will:

* Receive standard clinical care;
* Undergo two extra venipunctures for the collection of blood.

Conditions

  • Immunosuppression

Interventions

PROCEDURE

Venipunctures

Extra venipunctures

Sponsors & Collaborators

Principal Investigators

  • Brenda C.M. de Winter, PharmD, PhD · Erasmus Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-30
Primary Completion
2022-10-10
Completion
2022-11-10

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06342505 on ClinicalTrials.gov